This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barton, B. E.
Right arrow Articles by Jackson, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barton, B. E.
Right arrow Articles by Jackson, J. V.

 Previous Article  |  Next Article 

Infect. Immun., 03 1996, 714-718, Vol 64, No. 3
Copyright © 1996, American Society for Microbiology

Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model

BE Barton, J Shortall and JV Jackson
Department of Immunology, Schering-Plough Research Institute, Kenilworth, New Jersey 07033, USA.

BALB/By mice given doses of D-galactosamine plus Staphylococcus aureus enterotoxin B die within 48 h of administration. The cause of death is a syndrome much like toxic shock syndrome in humans. We used this model to investigate the role of two cytokines, interleukin 6 and interleukin 11, which share the signal transducing subunit, gp130, of their respective receptors. We observed that pretreatment of mice with antibody to interleukin 6 increased mortality from 55% to nearly 90% (P < 0.001), while pretreatment with either cytokine reduced death. The protection was dose dependent; however, interleukin 6 was about 10-fold more potent that interleukin 11. These data indicate that endogenous interleukin 6 plays a protective role in attenuating acute inflammatory responses; furthermore, interleukin 6 and interleukin 11 can abrogate T- cell activation due to triggering by superantigen. A possible clinical role for these cytokines in the treatment of toxic shock merits further investigation.


This article has been cited by other articles:

  • Varghese, T. K. Jr (2006). Invited commentary. Ann. Thorac. Surg. 82: 478-479 [Full Text]  
  • Silverstein, R. (2004). Review: D-Galactosamine lethality model: scope and limitations. Innate Immunity 10: 147-162 [Abstract]  
  • Malagarie-Cazenave, S., Segui, B., Leveque, S., Garcia, V., Carpentier, S., Altie, M.-F., Brouchet, A., Gouaze, V., Andrieu-Abadie, N., Barreira, Y., Benoist, H., Levade, T. (2004). Role of FAN in Tumor Necrosis Factor-{alpha} and Lipopolysaccharide-induced Interleukin-6 Secretion and Lethality in D-Galactosamine-sensitized Mice. J. Biol. Chem. 279: 18648-18655 [Abstract] [Full Text]  
  • Von der Thusen, J. H., Kuiper, J., Van Berkel, T. J. C., Biessen, E. A. L. (2003). Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential. Pharmacol. Rev. 55: 133-166 [Abstract] [Full Text]  
  • Hershko, D. D., Robb, B. W., Luo, G., Hasselgren, P.-O. (2002). Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283: R1140-R1148 [Abstract] [Full Text]  
  • Wang, Q., Fang, C. H., Hasselgren, P.-O. (2001). Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281: R1013-R1023 [Abstract] [Full Text]  
  • Curti, A., Ratta, M., Corinti, S., Girolomoni, G., Ricci, F., Tazzari, P., Siena, M., Grande, A., Fogli, M., Tura, S., Lemoli, R. M. (2001). Interleukin-11 induces Th2 polarization of human CD4+ T cells. Blood 97: 2758-2763 [Abstract] [Full Text]  
  • Komisar, J. L., Weng, C.-F., Oyejide, A., Hunt, R. E., Briscoe, C., Tseng, J. (2001). Cellular and Cytokine Responses in the Circulation and Tissue Reactions in the Lung of Rhesus Monkeys (Macaca mulatta) Pretreated with Cyclosporin A and Challenged with Staphylococcal Enterotoxin B. Toxicol Pathol 29: 369-378 [Abstract]  
  • Meng, Z. H., Dyer, K., Billiar, T. R., Tweardy, D. J. (2001). Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am. J. Physiol. Cell Physiol. 280: C343-C351 [Abstract] [Full Text]  
  • Wang, J., Homer, R. J., Chen, Q., Elias, J. A. (2000). Endogenous and Exogenous IL-6 Inhibit Aeroallergen-Induced Th2 Inflammation. J. Immunol. 165: 4051-4061 [Abstract] [Full Text]  
  • Roth, M, Block, L H (2000). Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines. Thorax 55: 678-684 [Abstract] [Full Text]  
  • Opal, S. M., DePalo, V. A. (2000). Anti-Inflammatory Cytokines. Chest 117: 1162-1172 [Abstract] [Full Text]  
  • Sheridan, B. C., Dinarello, C. A., Meldrum, D. R., Fullerton, D. A., Selzman, C. H., McIntyre, R. C. Jr. (1999). Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 277: L861-L867 [Abstract] [Full Text]  
  • Reznikov, L. L., Puren, A. J., Fantuzzi, G., Hamner, G. R., Schwertschlag, U. S., Ryan, J. L., Dinarello, C. A. (1999). Suppression of endotoxin-inducible cytokines in whole blood from human subjects following single dose of recombinant human interleukin-11. Innate Immunity 5: 197-204 [Abstract]  
  • Opal, S. M., Jhung, J. W., Keith, J. C. Jr, Goldman, S. J., Palardy, J. E., Parejo, N. A. (1999). Additive Effects of Human Recombinant Interleukin-11 and Granulocyte Colony-Stimulating Factor in Experimental Gram-Negative Sepsis. Blood 93: 3467-3472 [Abstract] [Full Text]  
  • Agnello, D., Meazza, C., Rowan, C. G., Villa, P., Ghezzi, P., Senaldi, G. (1998). Leptin causes body weight loss in the absence of in vivo activities typical of cytokines of the IL-6 family. Am. J. Physiol. Regul. Integr. Comp. Physiol. 275: R913-R919 [Abstract] [Full Text]  
  • Du, X., Williams, D. A. (1997). Interleukin-11: Review of Molecular, Cell Biology, and Clinical Use. Blood 89: 3897-3908 [Full Text]  
  • Wang, Y., Robledo, O., Kinzie, E., Blanchard, F., Richards, C., Miyajima, A., Baumann, H. (2000). Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor. J. Biol. Chem. 275: 25273-25285 [Abstract] [Full Text]